Literature DB >> 36038686

Outcomes of the Aurolab aqueous drainage implant and trabeculectomy with mitomycin C in iridocorneal endothelial syndrome.

Vijayalakshmi A Senthilkumar1, George Varghese Puthuran2, Techi Dodum Tara1,3, Nimrita Nagdev1, Sujitha Ramesh1, Iswarya Mani1, Subbaiah Ramasamy Krishnadas1, Steven Jon Gedde4.   

Abstract

PURPOSE: To compare the surgical outcomes of the Aurolab aqueous drainage implant (AADI) and trabeculectomy with mitomycin C (MMC) in patients with glaucoma secondary to iridocorneal endothelial (ICE) syndrome.
MATERIALS AND METHODS: This retrospective comparative case series included 41 eyes of 41 patients with ICE syndrome and glaucoma who underwent either a trabeculectomy with MMC (n = 20) or AADI surgery (n = 21) with a minimum of 2 years follow-up. Outcome measures included intraocular pressure (IOP), the use of glaucoma medications, visual acuity, additional surgical interventions, and surgical complications. Surgical failure was defined as IOP > 21 mmHg or reduced < 20% from baseline, IOP ≤ 5 mmHg, reoperation for glaucoma or a complication, or loss of light perception vision.
RESULTS: The cumulative probability of failure at 2 years was 50% in the trabeculectomy group (95%CI = 31-83%) and 24% in the AADI group (95%CI = 11-48%) (p = 0.09). The IOP was consistently lower in the AADI group compared with the trabeculectomy group at 6 months and thereafter. Surgical complications occurred in 13 eyes (65%) in the trabeculectomy group and 12 eyes (57%) in the AADI group (p = 0.71). Reoperations for glaucoma or complications were performed in 12 eyes (60%) in the trabeculectomy group and 5 patients (24%) in the tube group (p = 0.06). Cox proportional hazards showed that AADI had a 53% lower risk of failure at 2 years (p = 0.18; HR = 0.47; 95%CI = 0.16-1.40).
CONCLUSION: AADI surgery achieved lower mean IOPs than trabeculectomy with MMC in managing glaucoma secondary to ICE syndrome. A trend toward lower rates of surgical failure and reoperations for glaucoma and complications was observed following AADI placement compared with trabeculectomy with MMC in eyes with ICE syndrome.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Aurolab aqueous drainage implant; Glaucoma drainage devices; Iridocorneal endothelial syndrome; Trabeculectomy with mitomycin

Year:  2022        PMID: 36038686     DOI: 10.1007/s00417-022-05811-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.535


  20 in total

1.  Surgical results in iridocorneal endothelial syndrome.

Authors:  M Kidd; J Hetherington; S Magee
Journal:  Arch Ophthalmol       Date:  1988-02

2.  The corneal endothelium and the spectrum of essential iris atrophy.

Authors:  D G Campbell; M B Shields; T R Smith
Journal:  Am J Ophthalmol       Date:  1978-09       Impact factor: 5.258

3.  Iridocorneal endothelial syndrome: unification of a disease spectrum.

Authors:  M Yanoff
Journal:  Surv Ophthalmol       Date:  1979 Jul-Aug       Impact factor: 6.048

4.  Long-term outcome of aqueous shunt surgery in ten patients with iridocorneal endothelial syndrome.

Authors:  D K Kim; I M Aslanides; C M Schmidt; G L Spaeth; R P Wilson; J J Augsburger
Journal:  Ophthalmology       Date:  1999-05       Impact factor: 12.079

5.  Long-term surgical outcomes of patients with glaucoma secondary to the iridocorneal endothelial syndrome.

Authors:  E A Doe; D L Budenz; S J Gedde; N R Imami
Journal:  Ophthalmology       Date:  2001-10       Impact factor: 12.079

6.  Progressive essential iris atrophy, Chandler's syndrome, and the iris nevus (Cogan-Reese) syndrome: a spectrum of disease.

Authors:  M B Shields
Journal:  Surv Ophthalmol       Date:  1979 Jul-Aug       Impact factor: 6.048

7.  Glaucoma and the iridocorneal endothelial syndrome.

Authors:  H C Laganowski; M G Kerr Muir; R A Hitchings
Journal:  Arch Ophthalmol       Date:  1992-03

8.  Detection of herpes simplex viral DNA in the iridocorneal endothelial syndrome.

Authors:  J A Alvarado; J L Underwood; W R Green; S Wu; C G Murphy; D G Hwang; T E Moore; D O'Day
Journal:  Arch Ophthalmol       Date:  1994-12

9.  Specular microscopy of iridocorneal endothelia syndrome.

Authors:  L W Hirst; H A Quigley; W J Stark; M B Shields
Journal:  Am J Ophthalmol       Date:  1980-01       Impact factor: 5.258

10.  Glaucoma associated with iridocorneal endothelial syndrome in 203 Indian subjects.

Authors:  Premanand Chandran; Harsha L Rao; Anil K Mandal; Nikhil S Choudhari; Chandra S Garudadri; Sirisha Senthil
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.